TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$4.26M2010: -$7.73M2011: -$13.59M2012: -$19.68M2013: -$29.51M2015: -$44.54M2016: -$42.33M2017: -$30.52M2018: -$30.88M2019: -$31.95M2020: -$19.75M2021: -$23.56M2022: $1.06M2023: -$28.57M2024: -$23.09M2025: -$18.92M-$18.92M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$18.92M+18.1%
2024-$23.09M+19.2%
2023-$28.57M-2797.5%
2022$1.06M+104.5%
2021-$23.56M-19.3%
2020-$19.75M+38.2%
2019-$31.95M-3.4%
2018-$30.88M-1.2%
2017-$30.52M+27.9%
2016-$42.33M+5.0%
2015-$44.54M—
2013-$29.51M-49.9%
2012-$19.68M-44.8%
2011-$13.59M-75.8%
2010-$7.73M-81.5%
2009-$4.26M—